The protection of group B streptococcus type Ⅲ conjugation vaccine to newborn mice against lethal GBS infection

李莉,叶鸿瑁,沈叙庄,杨永弘,申阿东,Teresa Lagargard,黄德珉

DOI: https://doi.org/10.3760/j.issn:0578-1310.2002.01.005

2002-01-01

Abstract:Objective Group B streptococcus (GBS) is one of the important pathogens which cause neonatal meningitis, neonatal sepsis and neonatal pneumonia. It even can cause neonate death. In order to find out the methods of prevention and cure the diseases caused by GBS, we investigated the protection of type-specific antibody induced by active immunizing the pregnant mice with GBS type Ⅲ polysaccharide tetanus toxoid conjugate vaccine to newborn mice against lethal GBS infection. Methods Twenty SPF CD-1 pregnant mice were divided into three groups randomly. There were 8 pregnant mice in group A and B, 97 and 99 newborn mice in the two groups, respectively. Active immunize the pregnant mice in group A by injecting intra-peritoneally with 10 μg of GBS type Ⅲ polysaccharide-tetanus toxoid conjugate vaccine was carried out. In group B, the injection control group, the pregnant mice were injected with normal saline. While in group C there were 4 pregnant mice and 56 newborn mice not given any procedure served as normal control. There were 32 newborn mice both in group A and B served as samples for detecting the level of the antibody. Sixty-five (97 minus 32) and 67 (99 minus 32) newborn mice in group A and group B, respectively were challenged with lethal dose of the same type of GBS. Bacterial culture from spleen tissue was made in every dead mouse in group A and B. The type-specific antibody of the mother due to the immune response and the level of the same antibody in the newborn mice were measured with ELISA method. Results The amount of type-specific antibody in the pregnant mice in group A increased greatly after immunization. The geometric mean of the level of the antibody was increased from 0.039 mg/L before immunization to 0.728 mg/L after immunization (P0.001). The levels of this kind of antibody in newborn mice were higher than the infection control group, which was 0.538 mg/L and 0.043 mg/L, respectively (P0.001). The death rate of newborn mice in group A was 37% after lethal infection, however infection control group was 97% (P0.001). The bacterial culture from spleen tissue of the dead mice showed GBS positive result that indicated the deaths were caused by GBS. The survival rate in the normal control group was 100%, which suggested that the deaths were not caused by inequitable feeding and the environment.Conclusion The GBS type Ⅲ polysaccharide-tetanus toxoid conjugate vaccine could induce the type-specific antibody in pregnant mice which then passed to the newborn mice and protect them from lethal infection of GBS type Ⅲ. Humoral immune might play an important role in the anti-infection of GBS.